Disease Management & Health Outcomes

A Schema for Effective Osteoporosis Management: Outcomes of the Geisinger Health System Osteoporosis Program
pp. 611-616(6)
Author: Newman E.D.

Long-Term Effects of Second-Generation Cholinesterase Inhibitors on Clinical Outcomes and Costs of Alzheimer’s Disease
pp. 617-631(15)
Authors: Caro J.J.; Getsios D.

Provider Training and Education in Disease Management: Current and Innovative Technology
pp. 633-645(13)
Authors: Muramoto M.L.; Campbell J.; Salazar Z.

Global Efforts for Reducing the Burden of Smoking
pp. 647-661(15)
Authors: Chaloupka F.J.; Jha P.; Corrao M.A.; Silva V.L.d.C.e.; Ross H.; Ciecierski C.C.; Yach D.

Antibacterials for Viral Respiratory Infections: Results of a Physician-Based Intervention in a Predominantly Preferred Provider Organization Setting
pp. 663-671(9)
Authors: Berthiaume J.; Chernicoff H.O.; Kim J.J.; Chung R.S.; Pang R.C.; Legorreta A.P.

Management of Postmenopausal Osteoporosis: Defining the Role of Raloxifene
pp. 673-692(20)
Authors: Wellington K.; Plosker G.L.